Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm

There is no nonparenteral medication for the rapid termination of paroxysmal supraventricular tachycardia. The purpose of this study was to assess the efficacy and safety of etripamil nasal spray, a short-acting calcium-channel blocker, for the rapid termination of paroxysmal supraventricular tachyc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2018-07, Vol.72 (5), p.489-497
Hauptverfasser:	Stambler, Bruce S., Dorian, Paul, Sager, Philip T., Wight, Douglas, Douville, Philippe, Potvin, Diane, Shamszad, Pirouz, Haberman, Ronald J., Kuk, Richard S., Lakkireddy, Dhanunjaya R., Teixeira, Jose M., Bilchick, Kenneth C., Damle, Roger S., Bernstein, Robert C., Lam, Wilson W., O’Neill, Gearoid, Noseworthy, Peter A., Venkatachalam, Kalpathi L., Coutu, Benoit, Mondésert, Blandine, Plat, Francis
Format:	Artikel
Sprache:	eng
Schlagworte:	atrioventricular nodal re-entrant tachycardia atrioventricular reciprocating tachycardia Blood pressure Calcium calcium-channel blocker Cardiac arrhythmia Cardiology Conversion conversion rate Drug dosages Effectiveness Electrocardiography episodic treatment Heart rate Irritation Laboratories Medical instruments paroxysmal supraventricular tachycardia Patients Rhythm Safety Self-administration Sinuses Statistical analysis Statistical tests Studies Survival analysis Tachycardia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!